Credit: Getty Images Clinicians should consider non-urological contributing factors to OAB, such as medical comorbidities, according to the guideline panel. A 2024 AUA-SUFU guideline, which focuses on ...
PARK CITY, Utah, April 29, 2024 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of Revi TM, a patient-centric solution for urge urinary ...
Only 19% of patients were treated with oral and/or third-line therapies during 6-year study; third-line therapy increased from 2013 to 2018. (HealthDay News) — An increase in overactive bladder (OAB) ...
BALTIMORE, April 23, 2024 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA), in partnership with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU ...
—Maybe, say the results of a UK meta-analysis, which found some patients to benefit from the alternative approach. Considering the side effects of certain OAB medications and poor adherence, it’s ...
Overactive bladder is a long-term condition that won’t go away on its own and may worsen if a person does not get treatment. The condition can be caused by issues in how the brain and bladder ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The novel muscarinic M3 receptor antagonist DA8010 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback